Gyon Technologies Capital Management, LP Puma Biotechnology, Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.85 - $6.58 $32,672 - $75,433	-11,464 Closed	0 $0
Q3 2021 Nov 18, 2021	BUY	$6.63 - $9.39 $76,006 - $107,646	11,464 New	11,464 $80,000
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $131,826 - $191,556	-14,054 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $109,340 - $170,475	14,054 New	14,054 $144,000
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $282,577 - $331,359	-29,745 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.01 - $13.24 $208,512 - $393,823	29,745 New	29,745 $310,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $134M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.